Rajiv Malik
Net Worth
Last updated:
What is Rajiv Malik net worth?
The estimated net worth of Mr. Rajiv Malik is at least $37,984,533 as of 14 Jun 2024. He owns shares worth $6,913,508 as insider, has earned $3,591,025 from insider trading and has received compensation worth at least $27,480,000 in Viatris Inc..
What is the salary of Rajiv Malik?
Mr. Rajiv Malik salary is $6,870,000 per year as Pres & Executive Director in Viatris Inc..
How old is Rajiv Malik?
Mr. Rajiv Malik is 64 years old, born in 1961.
What stocks does Rajiv Malik currently own?
As insider, Mr. Rajiv Malik owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Viatris Inc. (VTRS) | Pres & Executive Director | 645,519 | $10.71 | $6,913,508 |
What does Viatris Inc. do?
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Rajiv Malik insider trading
Viatris Inc.
Mr. Rajiv Malik has made 2 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 264,300 units of VTRS stock worth $2,690,310 on 14 Jun 2024.
The largest trade he's ever made was exercising 264,300 units of VTRS stock on 14 Jun 2024. As of 14 Jun 2024 he still owns at least 645,519 units of VTRS stock.
Viatris key executives
Viatris Inc. executives and other stock owners filed with the SEC:
- Mr. Anthony Mauro (52) Pres of Developed Markets
- Mr. Michael Goettler (58) Chief Executive Officer & Executive Director
- Mr. Rajiv Malik (64) Pres & Executive Director
- Mr. Robert J. Coury (64) Executive Chairman
- Mr. Sanjeev Narula (64) Chief Financial Officer